AI filing briefs · archive

8-K filings in May 2025, explained

1,080 material Form 8-K filings that 839 companies we cover made with the SEC in May 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

4 of 1,080 briefs match

newest first · times in ET
STESTERIS plc May 14, 4:34 PM ET

STERIS fiscal 2025 revenue rises 6% to $5.5 billion; adjusted EPS $9.22

Positive earnings Written later 2.02

STERIS reported fiscal 2025 full-year revenue from continuing operations up 6% to $5.5 billion and diluted EPS from continuing operations of $6.16, up from $5.55. Fourth-quarter as reported diluted EPS slipped to $1.48 from $1.54 after a $48.2 million Illinois EO litigation settlement charge. The company also gave fiscal 2026 guidance of 6-7% revenue growth and adjusted EPS of $9.90 to $10.15.

  • Q4 fiscal 2025 revenue rose 4% to $1.5 billion; as reported diluted EPS was $1.48 versus $1.54 a year earlier
  • Full-year adjusted diluted EPS was $9.22, up from $8.20 in fiscal 2024
  • Fiscal 2026 outlook: revenue up 6-7% and adjusted EPS of $9.90 to $10.15, with tariffs estimated to reduce pre-tax profit by about $30 million
  • Free cash flow for fiscal 2025 was $787.2 million, up from $620.3 million
Read the filing on SEC.gov ↗
HWKNHAWKINS INC May 14, 4:08 PM ET

Hawkins Reports Record Fiscal 2025 Sales of $974.4 Million and Diluted EPS of $4.03

Positive earnings Written later 2.02

Hawkins reported record fourth-quarter and full-year fiscal 2025 results, with full-year sales up 6% to $974.4 million and diluted EPS up 12% to $4.03. The company expects all segments to grow in fiscal 2026 and revenue to surpass $1 billion, but expects EPS growth to slow due to higher interest and amortization expense.

  • Fourth-quarter sales rose 10% to $245.3 million and diluted EPS rose to $0.78 from $0.66 a year earlier.
  • Full-year Water Treatment sales rose 23% to $446.5 million, while Industrial sales fell 7% and Health and Nutrition sales fell 1%.
  • Net debt ended the year at $143.9 million, with a leverage ratio of 0.86x adjusted EBITDA; the company expects it to fall below 1x by the end of fiscal 2027.
  • Fiscal 2026 EPS is expected to grow more slowly than in recent years, and the company will report under new segments starting in the first quarter of fiscal 2026.
Read the filing on SEC.gov ↗
BOOTBoot Barn Holdings, Inc. May 14, 4:07 PM ET

Boot Barn Q4 sales rise 16.8% to $453.7 million; EPS $1.22; $200 million buyback

Positive earnings Written later 2.027.01

Boot Barn reported fourth-quarter and fiscal 2025 results for the periods ended March 29, 2025, with net sales up 16.8% to $453.7 million and net income of $37.5 million, or $1.22 per diluted share, versus $0.96 a year earlier. The board also authorized up to $200 million in share repurchases, and the company gave fiscal 2026 guidance with diluted EPS of $5.50 to $6.40 against $5.88 in fiscal 2025.

  • Q4 net sales rose 16.8% to $453.7 million; consolidated same store sales rose 6.0%.
  • Fiscal 2025 net income was $180.9 million, or $5.88 per diluted share, up from $4.80.
  • Board authorized repurchases of up to $200 million of common stock with no expiration date.
  • Fiscal 2026 guidance: total sales of $2.070 billion to $2.150 billion and diluted EPS of $5.50 to $6.40.
Read the filing on SEC.gov ↗
DTDynatrace, Inc. May 14, 6:32 AM ET

Dynatrace Q4 revenue rises 17% to $445 million; results exceed guidance

Positive earnings Written later 2.02

Dynatrace reported fourth-quarter and full-year fiscal 2025 results for the period ended March 31, 2025, saying Q4 results exceeded guidance on all key operating metrics. Fiscal 2026 guidance calls for total revenue of $1,950 million to $1,965 million, and the company repurchased 787,000 shares for $43 million in Q4 under a $500 million buyback program.

  • Q4 total revenue of $445 million, up 17% (19% constant currency); Q4 GAAP EPS was $0.13, flat versus the prior-year quarter
  • Full-year fiscal 2025 total revenue of $1,699 million, up 19%; GAAP EPS of $1.59 includes a $320.9 million income tax benefit from an intra-entity IP transfer
  • Fiscal 2026 full-year guidance: total revenue of $1,950 million to $1,965 million and non-GAAP EPS of $1.56 to $1.59
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.